IP Library Assignment 061954/0350
Patent Assignment
Reel/Frame 061954/0350

Assignment of Assignor's Interest

Recorded: 2022-12-02 Pages: 9
Assignors
MASUMOTO, SHUJI
Executed: 2019-12-13
TANAKA, HIROAKI
Executed: 2019-12-13
KUREBAYASHI, HIROTAKA
Executed: 2019-12-17
HASHIZUKA, TAKAHIKO
Executed: 2019-12-16
ARIKAWA, YUKA
Executed: 2019-12-12
Assignee
SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 5410045, JAPAN
Covered Property (1)
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
Application: 18/054,435 →
Publication: US 2023/0250116
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 2, 2022
From: SIDDIQUI-JAIN, ADAM; FLYNN, PAUL; FUJIWARA, YUJI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 061954/0230 →
Assignment of Assignor's Interest Dec 2, 2022
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 061954/0448 →
Merger Dec 2, 2022
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 061954/0493 →
Change of Name Dec 2, 2022
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 062050/0980 →
Change of Name Dec 2, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 062051/0070 →